Quantamental Technologies’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-16,865
Closed -$164K 543
2022
Q3
$164K Buy
16,865
+4,593
+37% +$60.8K 0.06% 435
2022
Q2
$178K Buy
+12,272
New +$209K 0.08% 360

Other funds holding HCAT

Quantamental Technologies's HCAT Position: Q4 2022 in Review

Quantamental Technologies sold out of Health Catalyst (HCAT) in Q4 2022, closing a stake of 16,865 shares — an estimated $164K sold.

Quantamental Technologies first reported a position in HCAT in Q2 2022 and held it in 2 quarters. The position peaked at $178K in Q2 2022. 166 funds tracked by Wall St. Rank hold HCAT as of Q4 2022.

  • Quantamental Technologies reported no remaining Health Catalyst position as of Q4 2022 after selling out during the quarter.
  • Quantamental Technologies sold 16,865 Health Catalyst shares in Q4 2022, an estimated $164K.
  • Quantamental Technologies first reported a position in Health Catalyst in Q2 2022 and held it in 2 quarters.
  • Quantamental Technologies's Health Catalyst position peaked at $178K in Q2 2022.
  • 166 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2022.

Based on Quantamental Technologies's 13F filing for Q4 2022, filed 14 Feb 2023.